MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
01-09-2015
-30-09-2021
Show more information
Organisation
MOTOR NEURONE DISEASE ASSOCIATION